The latest updates, press coverage, and industry insights from Proove Genomics.
April 26, 2024
Proove Genomics founder Brian Meshkin discusses the “predict-and-prevent” approach to chronic pain and opioid addiction, leveraging advanced genetics and a clinical data bank with over 153,000 patients.
Read More →April 21, 2024
Proove Genomics' predictive approach offers personalized pain management solutions that can address healthcare disparities among underserved populations, including African American women.
Read More →February 26, 2024
Proove Genomics' genetic testing provides personalized insights for chronic pain management, helping to address the growing epidemic affecting over 20% of Americans.
Read More →
March 10, 2025
Proove Genomics announces its relaunch, reinforcing its commitment to personalized pain diagnostics and predictive healthcare solutions for chronic pain and opioid addiction.
Read More →October 25, 2023
Outcomerus, a predictive health company founded by Brian Meshkin, launches to provide effective pain management solutions, building on the success of Proove Genomics' genetic testing platform.
Read More →Follow us for industry insights and company updates.
@Proovegenomics
@Proovegenomics
@Proovegenomics
Get the latest news and updates from Proove Genomics delivered to your inbox.
